Clinical Trials in Philadelphia

Showing 8781-8800 of 15,860 trials

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

NCT02527265

Primary Objective: -To assess the safety and tolerability of Afrezza in children ages 4 to 17 years with type 1 diabetes mellitus (T1DM). Secondary Objectives: * To assess the ability to titrate the prandial and supplemental doses of Afrezza at each meal. * To assess pharmacokinetics (PK) following a prandial dose of Afrezza in children ages 4 to 17 years with T1DM.

Type 1 Diabetes Mellitus

Mannkind Corporation30 participantsStarted Sep 2017

Los Angeles, California, United States • Aurora, Colorado, United States • New Haven, Connecticut, United States +10 more locations

TERMINATEDPhase 3< 1 mile

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

NCT01244191

This study is to determine if the combination regimen of tivantinib with erlotinib will improve overall survival relative to erlotinib alone in subjects with locally advanced or metastatic non-squamous, non-small cell lung cancer who have received 1 or 2 prior systemic anti-cancer therapies.

Non Squamous, Non-small-cell Lung Cancer

Daiichi Sankyo1,048 participantsStarted Jan 2011

Tucson, Arizona, United States • Tucson, Arizona, United States • Tucson, Arizona, United States +301 more locations

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Find Trials by Condition in Philadelphia

TSA Versus RSA in Patients >75

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

GLORIA-AF Registry Program - Second and Third Phases

Effects of Metformin During Nicotine Withdrawal

A Cognitive Bias Modification RCT for Aggression

Impact of CPAP Level on V/Q Mismatch in Premature Infants

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds

To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

The Diet Gout Trial

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children